U.S. Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Risk, By Method, By Technology, By Product, By Application (Trisomy, Microdeletion Syndrome), By End-use, And Segment Forecasts, 2023 - 2030

Market Segmentation

• U.S. NIPT Gestation Period Outlook (Volume, Number of Tests in Thousands; Revenue, USD Million, 2018 - 2030)
  • 0-12 weeks
  • 13-24
  • 25-35 weeks
• U.S. NIPT Risk Outlook (Revenue, USD Million, 2018 - 2030)
  • High & Average Risk
  • Low Risk
• U.S. NIPT Method Outlook (Volume, Number of Tests in Thousands; Revenue, USD Million, 2018 - 2030)
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests
• U.S. NIPT Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • NGS
  • Array Technology
  • PCR
  • Others
• U.S. NIPT Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Consumables & Reagents
  • Instruments
• U.S. NIPT Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Trisomy
  • Microdeletion Syndrome
  • Other Applications
• U.S. NIPT End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Diagnostic Laboratories

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance